[HTML][HTML] Next-generation treatments: Immunotherapy and advanced therapies for COVID-19
JA Arevalo-Romero, SM Chingaté-López, BA Camacho… - Heliyon, 2024 - cell.com
The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), emerged in 2019 following prior outbreaks of coronaviruses like SARS and …
(SARS-CoV-2), emerged in 2019 following prior outbreaks of coronaviruses like SARS and …
[PDF][PDF] Next generation immunotherapies–emerging strategies for immune modulation against cancer, infections, and beyond
JJ Moon, BG De Geest, X Sun - 2021 - deepblue.lib.umich.edu
Our special issue entitled “Next Generation Immunotherapies” focuses on emerging
strategies for immune activation, modulation, and tolerance in the context of immunotherapy …
strategies for immune activation, modulation, and tolerance in the context of immunotherapy …
New therapeutic approaches for SARS-CoV-2/COVID-19
AJ Rodriguez-Morales, AN Barbosa… - Frontiers in …, 2023 - frontiersin.org
After three years and a half since the pandemic due to the Severe Acute Respiratory
Syndrome coronavirus 2 (SARS-CoV-2) causing Coronavirus Disease 2019 (COVID-19) …
Syndrome coronavirus 2 (SARS-CoV-2) causing Coronavirus Disease 2019 (COVID-19) …
The immunology and immunotherapy for COVID-19
Y Liu, X Zhou, X Liu, X Jiang - Expert reviews in molecular medicine, 2021 - cambridge.org
The ongoing global pandemic of coronavirus disease 2019 (COVID-19) is caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and significantly impacts the world …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and significantly impacts the world …
Advances in immunotherapy for COVID-19: A comprehensive review
M Masoomikarimi, B Garmabi, J Alizadeh… - International …, 2021 - Elsevier
COVID-19 is an acute respiratory syndrome caused by SARS-COV-2 which has now
become a huge pandemic worldwide. The immunopathogenesis of COVID-19 has been …
become a huge pandemic worldwide. The immunopathogenesis of COVID-19 has been …
Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments
P Goodarzi, F Mahdavi, R Mirzaei, H Hasanvand… - International …, 2020 - Elsevier
The SARS-CoV-2 virus is an etiological agent of pandemic COVID-19, which spreads
rapidly worldwide. No proven effective therapies currently exist for this virus, and efforts to …
rapidly worldwide. No proven effective therapies currently exist for this virus, and efforts to …
Immunotherapy for SARS-CoV-2: potential opportunities
M Pashaei, N Rezaei - Expert opinion on biological therapy, 2020 - Taylor & Francis
Coronavirus Disease 2019 (COVID-19), caused by a novel coronavirus, called Severe Acute
Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), emerged at the end of 2019 in Wuhan …
Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), emerged at the end of 2019 in Wuhan …
[HTML][HTML] COVID-19 antiviral and treatment candidates: current status
E Españo, D Kim, J Kim, SK Park, JK Kim - Immune network, 2021 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute
respiratory syndrome coronavirus 2 has severely impacted global health and economy …
respiratory syndrome coronavirus 2 has severely impacted global health and economy …
SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines
X Li, Z Mi, Z Liu, P Rong - Frontiers in Microbiology, 2024 - frontiersin.org
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), emerged in December 2019 with staggering economic fallout …
coronavirus 2 (SARS-CoV-2), emerged in December 2019 with staggering economic fallout …
COVID-19: living through another pandemic
EEA Osman, PL Toogood, N Neamati - ACS Infectious Diseases, 2020 - ACS Publications
Novel beta-coronavirus SARS-CoV-2 is the pathogenic agent responsible for coronavirus
disease-2019 (COVID-19), a globally pandemic infectious disease. Due to its high virulence …
disease-2019 (COVID-19), a globally pandemic infectious disease. Due to its high virulence …